ReviewBMC urology2025
Malignant solitary fibrous tumor of the seminal vesicle: a case report and review of the literature.
Review in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Primary Neoplasms of the Seminal Vesicles: A Narrative Review of Carcinoma and the Rarer Non-Epithelial and Biphasic Tumours.Diagnostics (Basel, Switzerland) · 2026Review
- [Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSolitary fibrous tumors (SFTs) are rare mesenchymal tumors that can occur in multiple parts of the human body. The majority of SFTs are benign, with malignant cases being exceedingly rare. Although SFTs have been identified in extrapleural sites such as the upper respiratory tract, orbits, and extremities, their occurrence in the seminal vesicles is exceedingly uncommon. To date, only a few cases of seminal vesicle SFTs have been documented, making this case notable for its rarity and clinical presentation. CASE PRESENTATION: A 43-year-old male patient was incidentally found to have a left seminal vesicle mass on an MRI scan during a routine health check-up. A subsequent PET‒CT scan revealed enlargement of the left seminal vesicle with uneven density and FDG uptake, raising suspicion of malignancy. Although a biopsy suggested a solitary fibrous tumor of the seminal vesicle, the limited tissue sample prevented definitive exclusion of malignancy. This highlights the diagnostic challenges of such rare tumors, particularly when biopsy samples are insufficient. To address this, rapid intraoperative pathology was employed, which confirmed the malignancy and informed the patient of the subsequent surgical approach. The patient underwent laparoscopic excision of the left seminal vesicle tumor, followed by radical excision of both the prostate and seminal vesicles. Postoperatively, the patient recovered well, and final pathology confirmed a malignant solitary fibrous tumor. After five years of follow-up, the patient remained free from recurrence or metastasis.
conclusionAlthough the preoperative biopsy in this case established the diagnosis of SFT, it did not definitively ascertain whether it was benign or malignant. Hence, intraoperative frozen section pathology plays a critical role in determining the surgical strategy. This case indicates that satisfactory therapeutic outcomes for seminal vesicle SFTs can be achieved through complete resection via minimally invasive laparoscopic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.